Standout Papers
- ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia (2020)
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (2012)
Immediate Impact
3 from Science/Nature 58 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation
2024 Standout
Works of Daniel Lysák being referenced
Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy
2019
Valganciclovir Prophylaxis against Cytomegalovirus Impairs Lymphocyte Proliferation and Activation in Renal Transplant Recipients
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniel Lysák | 1024 | 637 | 316 | 570 | 78 | 1.8k | |
| W. Heit | 1268 | 490 | 570 | 593 | 94 | 2.2k | |
| Donna L. Forrest | 1336 | 722 | 258 | 411 | 109 | 2.2k | |
| Nicola Cascavilla | 1081 | 741 | 526 | 499 | 112 | 2.0k | |
| Robert Hast | 1418 | 575 | 314 | 452 | 97 | 2.0k | |
| Benet Nomdedeu | 869 | 814 | 284 | 355 | 89 | 1.8k | |
| Görgün Akpek | 1078 | 393 | 386 | 391 | 64 | 1.9k | |
| Blanca Xicoy | 1006 | 806 | 250 | 419 | 108 | 1.9k | |
| Alfonso Piciocchi | 979 | 508 | 201 | 320 | 100 | 1.7k | |
| Geoffrey Chan | 1192 | 782 | 564 | 722 | 89 | 2.4k | |
| Joan Bargay | 1540 | 364 | 236 | 666 | 71 | 1.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...